Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2022 Publisher: AFT Pharmaceuticals Limited, PO Box 33-203, Takapuna, Auckland 0740, Phone: 0800 423 823
Rubifen: Methylphenidate hydrochloride (USP) 5 mg, 10 mg and 20 mg.
Rubifen SR: Methylphenidate hydrochloride (USP) 20 mg sustained release tablets.
| Pharmaceutical Form |
|---|
|
Rubifen immediate release 5, 10 and 20 mg tablets: round white tablet with slightly bevelled edges, marked RU-5, RU-10 or RU-20 containing 5 mg, 10 mg and 20 mg methylphenidate respectively with a score mark on the 10 mg tablets. Rubifen sustained release 20 mg tablets: oblong white or white-cream smooth tablet containing 20 mg methylphenidate in a modified release formulation. |
Each 5mg tablet contains methylphenidate 5mg.
Each 10mg tablet contains methylphenidate 10mg.
Each 20mg tablet contains methylphenidate 20mg.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Methylphenidate |
Methylphenidate HCl is a mild central nervous system (CNS) stimulant. The mode of therapeutic action in Attention Deficit Hyperactivity Disorder (ADHD) is not known. Methylphenidate is thought to block the reuptake of noradrenaline and dopamine into the presynaptic neurone and increase the release of these monoamines into the extraneuronal space. |
| List of Excipients |
|---|
|
Rubifen (5 mg, 10 mg and 20 mg) contains calcium hydrogen phosphate dehydrate magnesium stearate, maize starch, and microcrystalline cellulose. Rubifen SR (20 mg) contains cetyl alcohol, ethylcellulose, lactose, magnesium stearate, and opadry white Y-1-7000. |
Rubifen (5 mg, 10 mg and 20 mg): Blister pack, PVC/Al, 30 tablets.
Rubifen SR (20 mg): Blister pack, PVC/PVdC AL (10 tbs/blister), 30 tablets.
AFT Pharmaceuticals Limited, PO Box 33-203, Takapuna, Auckland 0740, Phone: 0800 423 823
16/03/2000
| Drug | Countries | |
|---|---|---|
| RUBIFEN | Spain, Lithuania, Malta, New Zealand, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
